Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™

<p>Presentations highlight preclinical and clinical advancements of bexotegrast program in primary sclerosing cholangitis SOUTH SAN FRANCISCO, Calif., June 23, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that it presented Phase 2a clinical data and […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/pliant-therapeutics-presents-data-from-its-bexotegrast-program-at-the-european-association-for-the-study-of-the-liver-easl-international-liver-congress/">Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>